SKU: 0167ATC

EoL-1 cell Human

Tumor Cell Lines > Leukemia Cell Lines

Product Type: Human Leukemia Cell Lines

Species: Human

Cell Type: Lymphoblasts

Source Organ: Blood

Inquire about this product

Delivery and Shipping

Ship on dry ice.

Cell Name: EoL-1 cell

Cancer; Lifespan: infinite. Eosinophilic leukemia. Differenciate by n-butylate treatment.

  • Description
    EoL-1 is a human acute myeloid leukemia (AML) cell line derived from the peripheral blood of a 33-year-old male patient diagnosed with eosinophilic AML. This cell line exhibits myeloblast-like morphology and grow in suspension culture, with a doubling time of approximately 60 hours under standard conditions. Karyotypic analysis reveals a characteristic KMT2A (MLL) partial tandem duplication, a hallmark genetic alteration in specific AML subtypes. EoL-1 cells express eosinophilic lineage surface markers, including CD11b, CD13, and CD33, and exhibit interleukin-5 (IL-5) sensitivity, enabling their utility in studying eosinophil differentiation pathways .This cell line shows susceptibility to HIV-1 infection, further broadening their utility in modeling host-pathogen interactions. EoL-1 is tumorigenic and serves as a critical model for investigating AML pathophysiology, hematopoietic development, and drug screening.
  • Product Name
    EoL-1 cell
  • Product Type
    Human Leukemia Cell Lines
  • Species
    Human
  • Cell Type
    Lymphoblast
  • Source Organ
    Blood
  • Product Type
    Human Leukemia Cell Lines
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    EoL-1 serves as a valuable model in hematological malignancy research, especially in studies focusing on eosinophilic acute myeloid leukemia (AML) and KMT2A-rearranged leukemias. Its IL-5 responsiveness and eosinophilic marker expression allow for in-depth analysis of eosinophil lineage commitment and differentiation mechanisms. This cell line is also instrumental in evaluating chemotherapeutic agents targeting leukemic blasts or eosinophil differentiation pathways, enabling high-throughput drug efficacy and cytotoxicity screening. Additionally, EoL-1 provides a robust in vitro for exploring virus-host interactions, offering insights into the interplay between hematopoietic malignancies and viral pathogenesis.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    RPMI 1640 + 10% FBS
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    2

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

    Product inquiry

    Tell us what you need and our team will get back to you with pricing and availability.

    • Visit our support center

      Expert help & advice

    • Check your order status

      Updates & tracking

    • Returns & exchanges

      All you need to know

    • Price-match guarantee

      Our promise to you